Details for Patent: 8,802,714
✉ Email this page to a colleague
Which drugs does patent 8,802,714 protect, and when does it expire?
Patent 8,802,714 protects TPOXX and is included in one NDA.
This patent has thirty-four patent family members in twelve countries.
Summary for Patent: 8,802,714
| Title: | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| Abstract: | Methods of using di, tri, and tetracyclic acylhydrazide derivatives and analogs, as well as pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by the orthopoxvirus. |
| Inventor(s): | Jordan; Robert F. (Corvallis, OR), Bailey; Thomas R. (Phoenixville, PA), Rippin; Susan R. (Wilmington, DE), Dai; Dongcheng (Corvallis, OR) |
| Assignee: | Siga Technologies, Inc. (Corvallis, OR) |
| Application Number: | 13/966,392 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 8,802,714
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Siga Technologies | TPOXX | tecovirimat | SOLUTION;INTRAVENOUS | 214518-001 | May 18, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TPOXX IS INDICATED FOR THE TREATMENT OF HUMAN SMALLPOX DISEASE IN ADULTS AND PEDIATRIC PATIENTS WEIGHING AT LEAST 3 KG | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,802,714
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1638938 | ⤷ Sign Up | 301177 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1638938 | ⤷ Sign Up | 2022C/521 | Belgium | ⤷ Sign Up |
| European Patent Office | 1638938 | ⤷ Sign Up | 122022000032 | Germany | ⤷ Sign Up |
| European Patent Office | 1638938 | ⤷ Sign Up | 2290024-5 | Sweden | ⤷ Sign Up |
| European Patent Office | 1638938 | ⤷ Sign Up | C202230021 | Spain | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
